State-of-the-art mass spectrometry laboratory
A multi-million dollar investment by Griffith University allowed the establishment of a new glycomics and glycoproteomics focussed Advanced Mass Spectrometry Laboratory, embedded at the Institute for Glycomics.
As part of the ACRF International Centre for Cancer Glycomics (ACRF I2CG) a major focus of this Mass Spectrometry laboratory is to push the boundaries in biomedical research and working towards the discovery of new cancer diagnostics, drugs and vaccines, which will have global impact. This purpose built laboratory currently hosts three state-of-the-art high-end mass spectrometers catering for different challenges in cancer and disease glycomics.
We are using these modern technologies to understand and translate the glycome changes occurring in cancer to identify new therapeutic targets, develop novel diagnostics for precision medicine and gain a better general understanding of cancer biology.
We are also offering one-stop services and solutions for industrial glycomics and glycoproteomics challenges and questions, with the team having over 60 combined years of experience in analytical glycobiology, glycomics and glycoproteomics.
Equipment
The rapifleXTM tissue imager is used to visualise and identify diagnostic markers in tissue sections and understand their distribution in cancer tissues.
The OrbitrapTM FusionTM mass spectrometer is coupled to a nano-liquid chromatography system, enabling us to perform multi-dimensional separation, detection and fragmentation of biomolecules.
The amaZon speed ion trap mass spectrometer coupled to a nano-liquid chromatography system provides us with the opportunity to perform clinical glycomics with the highest sensitivity and selectivity.
Facility manager
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Pellentesque iaculis auctor dolor, non fermentum ante posuere et.
Enquiries
For further enquiries about our facility, please get in touch via email.